Lakeshore Acquisition I Corp. (NASDAQ:LAAA) disclosed this afternoon that its shareholders have approved its business combination with medical device company ProSomnus during a special meeting held earlier today.
Approximately 92.4% of the votes cast at the meeting on the business combination proposal, representing approximately 80.5% of Lakeshore’s outstanding shares, voted to approve the deal.
The SPAC disclosed in an 8-K that shareholders elected to redeem an aggregate of 2,402,027 ordinary shares in connection with the meeting.
Just yesterday, the SPAC entered into a non-redemption agreement with certain institutional investors for an aggregate of 200,339 shares and amended its purchaser support agreement with initial shareholders. Additionally, Lakeshore I secured $8.2 million in additional financing on Wednesday. Alongside the PIPE addition, Lakeshore I also secured an agreement from an investor to not redeem 195,000 shares in exchange for receiving 167,717 additional new shares. Together with the existing $30 million PIPE, Lakeshore I will be able to cover the deal’s $40 million minimum cash condition even with all other public shares redeemed.
The parties expect to close the deal on or about December 6. Following the closing, the combined company will operate as ProSomnus, Inc., and its shares of common stock and warrants are expected to trade on the Nasdaq Capital Market under the symbols “OSA” and “OSAW,” respectively, on December 7.
The parties initially announced the $168 million combination on May 10. Pleasanton, California-based ProSomnus customizes oral appliance therapy devices to treat obstructive sleep apnea.
ADVISORS
- Solomon Partners and Gordon Pointe Capital, LLC are acting as financial advisors to ProSomnus.
- Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. is acting as legal advisor to ProSomnus.
- Loeb & Loeb is acting as legal advisor to Lakeshore.
- Craig-Hallum Capital Group and Roth Capital Partners are acting as joint placement agents on the PIPE.
- Craig-Hallum Capital Group is acting as M&A advisor to Lakeshore.
Terms Tracker for the Week Ending March 15, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Maybe it’s the weather, but there was a perceptible change this week in the air. That’s not to say that we should expect a big...
Deals and Amendments Keyarch (NASDAQ:KYCH) has tweaked the earnout provision of its combination with EV charging firm ZOOZ Power. Under the new terms, ZOOZ shareholders will still receive 1,000,000 shares if it achieves $10 million or more in gross revenue for any four quarters within five or if its shares hit a VWAP of $12....
In the current market conditions, SPACs looking for a target have to thread multiple needles at once. Many in the market now – particularly of the 2021 vintage – set out with teams experienced in high-growth technology sectors, but a risk-off market spooked by inflation has expressed itself in an appetite for more “sure things.”...
At the SPAC of Dawn Despite some Thursday ripples in the market on economic data readings, there appears to be growing consensus that the Fed won’t budge much over its initial plans for three rate cuts in 2024 and four more in 2025. But, other regulatory changes could have more direct impact on de-SPACs this...
News and Rumors PR: eVTOL maker Lilium (NASDAQ:LILM) has partnered with Atlantic Aviation to provide infrastructure support Lilium’s launch into Florida, California, Texas and Northeast US markets. The two will collaborate on the planning aspects of integrating Lilium aircraft and regional jet service operations into airports. Lilium combined with Qell in September 2021. PR: Construction...